Additionally, in ovarian cancer (OC) patients, circulating CXCL1, CCL4, and CCL20 are elevated in serum specimens, which are associated with shorter recurrence-free survival (RFS) and OS. This evidence concerns the gene CCL4 and ovarian cancer.